Stock KRTX KARA THER
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News KARA THER

Equities

KRTX

US48576A1007

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Karuna Therapeutics, Inc.(NasdaqGM:KRTX) dropped from S&P Biotechnology Select Industry Index
CI
Karuna Therapeutics, Inc.(NasdaqGM:KRTX) dropped from S&P TMI Index
CI
Karuna Therapeutics, Inc.(NasdaqGM:KRTX) dropped from S&P Global BMI Index
CI
Bristol-Myers Squibb Completes Karuna Therapeutics Acquisition
MT
PureTech Health: Bristol Myers Squibb Wraps Up $14 Billion Acquisition of Karuna
MT
KARA THER : Acquisition/Asset Disposal - Form 8-K
PU
Karuna Therapeutics, Inc. and Miramar Merger Sub Inc. Announce Management Changes
CI
Bristol Myers: completes acquisition of Karuna Therapeutics
CF
Karuna Therapeutics, Inc.(NasdaqGM:KRTX) dropped from NASDAQ Composite Index
CI
Bristol-Myers Squibb Company completed the acquisition of Karuna Therapeutics, Inc. from Capital International Investors, FMR LLC, The Vanguard Group, Inc., T. Rowe Price Group, Inc. and others.
CI
Karuna Therapeutics, Inc.(NasdaqGM:KRTX) dropped from NASDAQ Biotechnology Index
CI
Karuna Therapeutics : Material Event - Form 8-K
PU
Karuna Therapeutics Q4 Loss Widens
MT
Karuna Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Karuna Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business Update
BU
KARUNA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Karuna Therapeutics, Inc. - KRTX
BU
Bristol Myers Squibb Reportedly Eyeing $13 Billion from Bond Sale Launched Wednesday
MT
Bristol-Myers Squibb's New Product Performance Mixed as Headwinds Persist, Morgan Stanley Says
MT
Bristol Myers posts better-than-expected 4th-quarter results
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KRTX Stock
  4. News KARA THER